每周股票复盘：心脉医疗（688016）取消监事会并修订章程

Core Viewpoint - The company, Shanghai MicroPort CardioFlow Medtech Co., Ltd., has successfully held its first extraordinary general meeting of shareholders in 2025, where significant resolutions were passed, including the cancellation of the supervisory board and amendments to the company's articles of association [1][2][3] Group 1: Stock Performance - As of the market close on November 14, 2025, the stock price of MicroPort CardioFlow was 102.25 yuan, reflecting a 4.62% increase from the previous week's price of 97.73 yuan [1] - The stock reached a peak price of 105.94 yuan during the trading session on November 14, 2025, and a low of 97.5 yuan on November 10, 2025 [1] - The company's current total market capitalization stands at 12.604 billion yuan, ranking 25th out of 126 in the medical device sector and 1537th out of 5165 in the overall A-share market [1] Group 2: Shareholder Meeting Outcomes - The extraordinary general meeting on November 14, 2025, was conducted with both in-person and online voting, presided over by Chairman Jonathan Chen, and the voting results were deemed legally valid [2] - Key resolutions passed included the cancellation of the supervisory board, amendments to the articles of association, and the purchase of liability insurance for directors and senior management, with the cancellation of the supervisory board requiring a special resolution that received over two-thirds approval from voting shareholders [2][3] - Additionally, a workers' representative meeting was held on the same day, resulting in the election of Yuan Zhenyu as a worker representative director for the third board of directors, with his term starting immediately upon approval [2]